Feed HOLX
HO

Hologic HOLX · NASDAQ

$76.01 +0.00% (+$0.00)

Market cap
$17.0B
Enterprise value
$17.6B
P/E
30.6x
Forward P/E
-
PEG
-
P/S
4.1x
P/FCF
18.1x
EV/EBITDA
16.3x
ROIC
7.3%
Gross margin
53.0%
Net margin
13.8%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
0.6x
Beta
0.70
Free float
99.1%

About the company

Hologic, Inc. (HOLX) is an American company operating in the field of medical technologies and diagnostic solutions. The company specializes in the development, manufacturing, and sale of innovative medical devices and diagnostic tests for women's health. Its products include mammography systems, devices for osteoporosis diagnosis, cytology and molecular diagnostic systems, among others. Hologic holds a strong market position in women's health and is known for its advanced technologies and high-quality diagnostic solutions. The company focuses on providing innovative tools and technologies that enable early detection and diagnosis of diseases, contributing to the improvement of patients' health outcomes. Investors seeking exposure to the healthcare sector and technologies for women's health may consider shares of Hologic, Inc. (HOLX) as an interesting investment opportunity.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Paul Malenchini

Employees

7,063

Headquarters

Marlborough

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.